Literature DB >> 26334161

Pharmacological and emerging therapies in the treatment of chronic angina.

Steen E Husted1, E Magnus Ohman2.   

Abstract

Chronic angina is a common manifestation of ischaemic heart disease. Medical treatments are the mainstay approach to reduce the occurrence of angina and improve patients' quality of life. This Series paper focuses on commonly used standard treatments (eg, nitrates, β blockers, and calcium-channel blockers), emerging anti-angina treatments (which are not available in all parts of the world), and experimental treatments. Although many emerging treatments are available, evidence is scarce about their ability to reduce angina and ischaemia.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26334161     DOI: 10.1016/S0140-6736(15)61283-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  Relief of Ischemia in Ischemic Cardiomyopathy.

Authors:  Francesco Moroni; Zachary Gertz; Lorenzo Azzalini
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 2.  Drug Therapy for Stable Angina Pectoris.

Authors:  Talla A Rousan; Sunil T Mathew; Udho Thadani
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 3.  Expert consensus document: A 'diamond' approach to personalized treatment of angina.

Authors:  Roberto Ferrari; Paolo G Camici; Filippo Crea; Nicolas Danchin; Kim Fox; Aldo P Maggioni; Athanasios J Manolis; Mario Marzilli; Giuseppe M C Rosano; José L Lopez-Sendon
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

Review 4.  The Real Role of β-Blockers in Daily Cardiovascular Therapy.

Authors:  Csaba András Dézsi; Veronika Szentes
Journal:  Am J Cardiovasc Drugs       Date:  2017-10       Impact factor: 3.571

Review 5.  A pathophysiological compass to personalize antianginal drug treatment.

Authors:  Edoardo Bertero; Gerd Heusch; Thomas Münzel; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2021-07-07       Impact factor: 32.419

Review 6.  Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.

Authors:  Julian Bejarano; Mario Navarro-Marquez; Francisco Morales-Zavala; Javier O Morales; Ivonne Garcia-Carvajal; Eyleen Araya-Fuentes; Yvo Flores; Hugo E Verdejo; Pablo F Castro; Sergio Lavandero; Marcelo J Kogan
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

7.  International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.

Authors:  Jules Mesnier; Gregory Ducrocq; Nicolas Danchin; Roberto Ferrari; Ian Ford; Jean-Claude Tardif; Michal Tendera; Kim M Fox; Philippe Gabriel Steg
Journal:  Circulation       Date:  2021-07-15       Impact factor: 29.690

Review 8.  Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology.

Authors:  Alexandra Petraina; Cristian Nogales; Thomas Krahn; Hermann Mucke; Thomas F Lüscher; Rodolphe Fischmeister; David A Kass; John C Burnett; Adrian J Hobbs; Harald H H W Schmidt
Journal:  Cardiovasc Res       Date:  2022-07-20       Impact factor: 13.081

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.